14 results
·
25ms
·
Sources: EU EUDAMED, US FDA
LESIONPOINT RF CANNULA
FDA 510(k)
FDA Class 2
·Neurology
Navagio
FDA UDI
Kalitec Direct LLC·B07330K0134150·Trial, TLIF, 27L OB STR 7Deg, 15mm
ANEROID SPHYGMOMANOMETER WITH STETHOSCOPE
FDA 510(k)
FDA Class 2
·Cardiovascular
SYNTHES ANKLE ARTHRODESIS PLATE
FDA 510(k)
FDA Class 2
·Orthopedic
SMARTSET GHV GENTAMICIN 40G
FDA Adverse Event
Injury
·DEPUY CMW - 9610921·Product code LOD·March 3, 2020
SMARTSET GHV GENTAMICIN 40G
FDA Adverse Event
Injury
·DEPUY ORTHOPAEDICS INC US·Product code MBB·January 11, 2021
SMARTSET GHV GENTAMICIN 40G
FDA Adverse Event
Injury
·DEPUY ORTHOPAEDICS INC US·Product code MBB·May 20, 2021
SMARTSET GHV GENTAMICIN 40G
FDA Adverse Event
Injury
·DEPUY ORTHOPAEDICS INC US·Product code MBB·January 11, 2021
ONETOUCHPING GLUCOSEMGMTSYSTEM
FDA Adverse Event
Malfunction
·ANIMAS CORPORATION·Product code LZG·April 11, 2013
TRILLIUM AFFINITY NT HOLLOW FIBER OXYGENATOR
FDA Adverse Event
Injury
·MEDTRONIC PERFUSION SYSTEMS·Product code DTZ·May 23, 2008
SPRINT QUATTRO SECURE
FDA Adverse Event
Malfunction
·MEDTRONIC PUERTO RICO, INC.·Product code LWS·April 13, 2011
Cocoon Convective Warming System, Product Code: CWS4000 (110V).
FDA Enforcement
Class II
·Terminated·Care Essentials Pty., Ltd.·February 12, 2020
Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone
FDA Enforcement
Class II
·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012
Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014